Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert P Li

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
Chemico-Biological Interactions|November 20, 2015
Evaluation of multiple mechanism-based toxicity endpoints in primary cultured human hepatocytes for the identification of drugs with clinical hepatotoxicity: Results from 152 marketed drugs with known liver injury profilesJie Zhang, Utkarsh Doshi, Ayako Suzuki, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 4, 2019
Development and Validation of a Higher-Throughput Cytochrome P450 Inhibition Assay with the Novel Cofactor-Supplemented Permeabilized Cryopreserved Human Hepatocytes (MetMax Human Hepatocytes)Veera Raghava Choudary Palacharla, Prathyusha Chunduru, Devender Reddy Ajjala, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 2, 2018
Prediction of the Pharmacokinetics of Pravastatin as an OATP Substrate Using Plateable Human Hepatocytes With Human Plasma Data and PBPK ModelingJialin Mao, Utkarsh Doshi, Matthew Wright, et al.
Drug Metabolism Letters|March 18, 2014
Culture duration-, donor-, and medium-dependent changes in OATP1B3-mediated telmisartan uptake in human hepatocytesQing Zhu, Haiyan Xia, Cindy Q Xia, et al.
The Journal of Pharmacy and Pharmacology|November 8, 2003
Effect of bupropion on CYP2B6 and CYP3A4 catalytic activity, immunoreactive protein and mRNA levels in primary human hepatocytes: comparison with rifampicinLeah M Hesse, Yumiko Sakai, Daesety Vishnuvardhan, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 15, 2018
Cryopreserved Human Intestinal Mucosal Epithelium: A Novel In Vitro Experimental System for the Evaluation of Enteric Drug Metabolism, Cytochrome P450 Induction, and EnterotoxicityAlbert P Li, Novera Alam, Kirsten Amaral, et al.
Chemico-Biological Interactions|October 26, 2002
Correlation between troglitazone cytotoxicity and drug metabolic enzyme activities in cryopreserved human hepatocytesNicola J Hewitt, Scott Lloyd, Mike Hayden, et al.
Chemico-Biological Interactions|October 26, 2002
Identification of glutathione conjugates of troglitazone in human hepatocytesSaileta Prabhu, Andrew Fackett, Scott Lloyd, et al.
Biochemical Pharmacology|July 21, 2018
Strategies and limitations associated with in vitro characterization of vitamin D receptor activatorsPaola Bukuroshi, Hiroshi Saitoh, Lilia Magomedova, et al.
Chemico-Biological Interactions|October 26, 2002
Differential in vitro hepatotoxicity of troglitazone and rosiglitazone among cryopreserved human hepatocytes from 37 donorsScott Lloyd, Michael J Hayden, Yumiko Sakai, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Chemico-Biological Interactions|November 20, 2015
Evaluation of multiple mechanism-based toxicity endpoints in primary cultured human hepatocytes for the identification of drugs with clinical hepatotoxicity: Results from 152 marketed drugs with known liver injury profilesJie Zhang, Utkarsh Doshi, Ayako Suzuki, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 4, 2019
Development and Validation of a Higher-Throughput Cytochrome P450 Inhibition Assay with the Novel Cofactor-Supplemented Permeabilized Cryopreserved Human Hepatocytes (MetMax Human Hepatocytes)Veera Raghava Choudary Palacharla, Prathyusha Chunduru, Devender Reddy Ajjala, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 2, 2018
Prediction of the Pharmacokinetics of Pravastatin as an OATP Substrate Using Plateable Human Hepatocytes With Human Plasma Data and PBPK ModelingJialin Mao, Utkarsh Doshi, Matthew Wright, et al.
Drug Metabolism Letters|March 18, 2014
Culture duration-, donor-, and medium-dependent changes in OATP1B3-mediated telmisartan uptake in human hepatocytesQing Zhu, Haiyan Xia, Cindy Q Xia, et al.
The Journal of Pharmacy and Pharmacology|November 8, 2003
Effect of bupropion on CYP2B6 and CYP3A4 catalytic activity, immunoreactive protein and mRNA levels in primary human hepatocytes: comparison with rifampicinLeah M Hesse, Yumiko Sakai, Daesety Vishnuvardhan, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 15, 2018
Cryopreserved Human Intestinal Mucosal Epithelium: A Novel In Vitro Experimental System for the Evaluation of Enteric Drug Metabolism, Cytochrome P450 Induction, and EnterotoxicityAlbert P Li, Novera Alam, Kirsten Amaral, et al.
Chemico-Biological Interactions|October 26, 2002
Correlation between troglitazone cytotoxicity and drug metabolic enzyme activities in cryopreserved human hepatocytesNicola J Hewitt, Scott Lloyd, Mike Hayden, et al.
Chemico-Biological Interactions|October 26, 2002
Identification of glutathione conjugates of troglitazone in human hepatocytesSaileta Prabhu, Andrew Fackett, Scott Lloyd, et al.
Biochemical Pharmacology|July 21, 2018
Strategies and limitations associated with in vitro characterization of vitamin D receptor activatorsPaola Bukuroshi, Hiroshi Saitoh, Lilia Magomedova, et al.
Chemico-Biological Interactions|October 26, 2002
Differential in vitro hepatotoxicity of troglitazone and rosiglitazone among cryopreserved human hepatocytes from 37 donorsScott Lloyd, Michael J Hayden, Yumiko Sakai, et al.
Pageof 8